Tesamorelin / Ipamorelin
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Back to peptide library
Metabolic GH-support stack
Tesamorelin / Ipamorelin / MOTS-c
A combined body-composition and metabolic-support conversation involving growth-hormone pathway support from Tesamorelin and Ipamorelin plus mitochondrial signaling support from MOTS-c.
GH pathway support MOTS-c metabolic signaling IPS related listings Clinical screening required
Overview
What is the Tesa/IPA/MOTS-c blend?
a triple blend combining Tesamorelin for GHRH pathway support, Ipamorelin for selective ghrelin-receptor GH signaling, and MOTS-c for mitochondrial and AMPK-related metabolic support.
IPS does not currently show one exact Tesa/IPA/MOTS-c triple-blend card. The available list lists related options including Tesamorelin / Ipamorelin, MOTS-C, and MOTs-C/Tesamorelin.
Common program goals
- Discuss body-composition and visceral-fat support goals
- Review GH signaling, recovery, sleep, and metabolic health
- Evaluate glucose markers, medications, training, and nutrition
- Compare related IPS listings and determine what is available
- Track labs, tolerance, recovery, body composition, and energy
IPS access
Available related IPS listings.
These entries come from the IPS access available list. Final route, timing, duration, and candidacy depend on consultation, availability, and clinician judgment.
MOTs-C/Tesamorelin
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
MOTS-C
This IPS-listed option is reviewed privately during consultation. Details are reviewed privately during consultation.
Mechanism
GH support plus mitochondrial signaling.
This stack is commonly framed around three complementary ideas: GHRH signaling, ghrelin-receptor amplification, and AMPK-related mitochondrial support. IPS translates that into practical screening, lab review, and measurable outcomes.
Tesamorelin
A GHRH analog discussed for growth-hormone support and body-composition conversations.
Ipamorelin
Often discussed for selective GH secretion through ghrelin-receptor activity.
MOTS-c
A mitochondrial-derived peptide discussed around AMPK, glucose metabolism, and cellular energy.
Integrated plan
Nutrition, strength training, sleep, metabolic labs, and medication review remain central.
Process
How metabolic GH-stack care works at IPS.
Metabolic Review
Review body composition, waist changes, energy, sleep, training, nutrition, glucose markers, and medications.
Clinical Screening
Screen cancer history, pituitary history, diabetes medications, sleep apnea risk, pregnancy-related factors, and lab needs.
Protocol Design
If appropriate, your clinician reviews related listings, route, timing, frequency, and monitoring expectations.
Follow-Up
Follow-up tracks tolerance, labs, body-composition trends, sleep, energy, and recovery.
Safety & candidacy
Metabolic and GH-active protocols need screening.
IPS reviews IGF-1 context, glucose status, diabetes or GLP-1 medication use, cancer history, pituitary history, cardiovascular symptoms, sleep apnea risk, pregnancy-related factors where applicable, and whether labs are needed.
Common effectsInjection-site irritation, water retention, hunger changes, nausea, headache, fatigue, or blood-sugar shifts may occur.
Blood sugarPeople using diabetes, weight-loss, thyroid, or stimulant medications need careful review.
MonitoringLab review may include glucose markers, IGF-1, metabolic markers, and other clinician-selected measures.
No guaranteesResponse varies, and this page is educational rather than a promise of fat loss or hormone optimization.
Questions
Frequently asked.
Does IPS list one Tesa/IPA/MOTS-c blend?
The current available list does not show one exact triple-blend card. It lists Tesamorelin / Ipamorelin, MOTS-C, and MOTs-C/Tesamorelin as related options.
Why combine these concepts?
The reference blend pairs GH pathway support with mitochondrial and metabolic signaling for body-composition and recovery conversations.
Is this a weight-loss medication?
No. It is discussed for metabolic and GH-support education. Weight goals should be reviewed with nutrition, training, labs, and medical history.
Can it replace GLP-1 or diabetes care?
No. Medication changes and diabetes care should be managed by the prescribing clinician.
Contact
Ask IPS about Tesamorelin, Ipamorelin, and MOTS-c eligibility.
Complete the form and IPS will follow up about consultation scheduling and next steps.
Medical note This page is educational and is not intended to diagnose, treat, cure, or prevent disease. Peptide decisions require consultation with a qualified clinician.